Unlock instant, AI-driven research and patent intelligence for your innovation.

An organic solvent-resistant galactosidase high-yielding bacterium and the gene and application of the galactosidase

A technology of galactosidase and resistance to organic solvents, applied in the field of biopharmaceuticals, can solve the problems of low product molar conversion rate, high price, low substrate concentration, etc., and achieve the effect of good application potential

Active Publication Date: 2018-10-19
NANJING TECH UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The object of the present invention is to provide an organic solvent-resistant drug for the problems of expensive sugar donors, low substrate concentration before glycosylation conversion, and low product molar conversion rate in the current glycosylation-modified nucleoside drugs. A beta-galactosidase with good tolerance and lactose as a glycosyl donor and its producing bacteria contain a recombinant expression vector encoding the enzyme gene, a recombinant expression transformant and a high-efficiency preparation method thereof, and a lactose-supplied β-galactosidase Method for enzymatic galactosylation of nucleoside compounds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An organic solvent-resistant galactosidase high-yielding bacterium and the gene and application of the galactosidase
  • An organic solvent-resistant galactosidase high-yielding bacterium and the gene and application of the galactosidase
  • An organic solvent-resistant galactosidase high-yielding bacterium and the gene and application of the galactosidase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] This example illustrates the screening procedure for organic solvent-resistant strains of galactosylation-modified nucleoside drugs.

[0040] The following method is used for primary screening: with X-Gal (5-bromo-4-chloro-3- indole -β-D-galactoside) as the substrate, inoculate the strains in the organic solvent-resistant bacterial library in our laboratory to the screening plate, and directly observe the color change of the plate, if it turns blue, it means that the strain has β-galactoside Glycosidase hydrolytic activity. The specific screening medium formula is: lactose 10 g / L, yeast extract 5 g / L, tryptone 10 g / L, NaCl 10 g / L, MgSO 4 0.5 g / L, K 2 HPO 4 2.5g / L, X-Gal 0.1g / L, pH 7.0, agar 20g / L. The culture temperature is 37 ℃, and the culture time is 12-36 h. This method can screen a large number of organic solvent-resistant β-galactosidase-producing bacteria.

[0041] The strains obtained from the primary screening were re-screened, and the specific method ...

Embodiment 2

[0043] This example illustrates the biological properties and identification of the organic solvent-resistant galactosidase-producing bacterium YZ09.

[0044] Biological properties of the strain YZ09: the strain is a Gram-positive bacterium without spores. The bacterial body is a bacillus under the microscope, facultatively anaerobic, and the optimum growth temperature is 30-40 ℃. Its physiological and biochemical characteristics are manifested in: catalase reaction results are negative, gelatin reaction results are negative, no exercise, glucose is oxidized to produce acid, and lactose, sucrose, sorbitol, xylose, fructose, maltose, mannitol, etc. can be utilized.

[0045] After 16S rDNA sequence analysis, strain YZ09 was identified as Lactobacillus casei ( Lactobacillus casei ), named Lactobacillus casei ( Lactobacillus casei ) YZ09.

[0046] Lactobacillus casei ( Lactobacillus casei ) YZ09, has been preserved. Classified as Lactobacillus casei ( Lactobacillus casei ...

Embodiment 3

[0048] This example illustrates Lactobacillus casei ( Lactobacillus casei ) YZ09 fermentation enzyme production method.

[0049] Plate medium formula: peptone 10 g / L, beef extract 10 g / L, yeast extract 5 g / L, glucose 20 g / L, K 2 HPO 4 2 g / L, sodium zirconate 5 g / L, citric acid 2 g / L, magnesium sulfate 0.2 g / L, manganese sulfate 0.2 g / L, agar 20 g / L, pH6.5, soluble in water.

[0050] Seed medium formula: peptone 10 g / L, beef extract 10 g / L, yeast extract 5 g / L, glucose 20 g / L, K 2 HPO 4 2 g / L, sodium zirconate 5 g / L, citric acid 2 g / L, magnesium sulfate 0.2 g / L, manganese sulfate 0.2 g / L, pH6.5, soluble in water.

[0051] Seed solution preparation: The volume of seed solution medium in a 250 mL Erlenmeyer flask was 40 mL. The strain YZ09 cultured on the plate for 24 h was scraped and inserted into the seed medium, the rotation speed of the shaker was 180 rpm, the culture temperature was 37 °C, and the culture time was 10-12 h to obtain the seed liquid.

[0052] Enzyme ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an organic solvent-resistant galactosidase high-yield bacterial strain, a galactosidase and a method for enzymatically galactosylating nucleoside compounds with lactose as a donor. The strain is classified as Lactobacillus casei YZ09, and its preservation number is: CCTCC NO: M 2014540. The invention isolates and clones the organic solvent-resistant galactosidase gene produced by the bacterial strain, which has the nucleotide sequence shown in SEQ ID NO:1. The galactosidase produced by the strain YZ09 has the properties of good solvent tolerance, wide pH range and good substrate specificity. The galactosidase can modify nucleoside drugs in a non-aqueous phase system with cheap and easy-to-obtain lactose as a donor, and has good industrial application value.

Description

technical field [0001] The invention relates to an organic solvent-resistant galactosidase high-yielding bacterium, which is resistant to organic solvent galactosidase, and a method for enzymatically galactosylating nucleoside compounds using lactose as a donor, belonging to the technical field of biopharmaceuticals . technical background [0002] Azidothymidine, acyclovir and other nucleoside drugs are an important class of anti-tumor and anti-viral drugs, which are widely used in the clinical treatment of various cancers. Azidothymidine is the first anti-HIV virus drug, and acyclovir is currently one of the most effective anti-type I and type II herpes simplex viruses clinically. Other herpes viruses are also effective. However, azidothymidine causes strong toxic and side effects due to high plasma concentration, and acyclovir has certain toxic and side effects on the blood system, nervous system, and digestive system. In order to obtain the best therapeutic effect and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/20C12N9/38C12N1/21C12N15/70C12P19/38C12R1/245
CPCC12P19/38C12N1/205C12R2001/245
Inventor 何冰芳周有治储建林张劲松刘柯吴斌钦松柏中中姜天玥
Owner NANJING TECH UNIV